Literature DB >> 26563201

Discordant cardiac biomarker levels independently predict outcome in ST-segment elevation myocardial infarction.

Gregor Leibundgut1, Michael Gick1, Olivier Morel2, Miroslaw Ferenc1, Klaus-Dieter Werner1, Thomas Comberg1, Rolf-Peter Kienzle1, Heinz Joachim Buettner1, Franz-Josef Neumann3.   

Abstract

AIMS: To investigate the prognostic relevance of elevated Troponin T (cTnT) levels in patients with ST-segment elevation myocardial infarction (STEMI) without significant creatine kinase (CK) elevation on admission. METHODS AND
RESULTS: From January 1, 2002 to December 31, 2006 patients with STEMI without significant CK elevation (<2-fold) on admission treated with percutaneous coronary intervention (PCI) were included and stratified according to cTnT plasma levels. Univariate and multivariate regression analyses were used to find independent predictors for mortality. During the 5-year period 514 patients with STEMI and normal CK plasma levels were included. 308 (59.9 %) patients had cTnT levels <0.1 μg/l and 206 (40.1 %) patients had cTnT levels ≥0.1 μg/l. Multivariate logistic regression analysis identified cTnT levels ≥0.1 μg/l and 3-vessel disease as positive, and hemoglobin levels as negative independent predictors for long-term mortality. Discordantly elevated cTnT plasma levels independently predicted higher mortality rates in the first year (HR 3.9, 95 % CI 1.7-9.1, p = 0.002) and during 5 years (HR 2.3, 95 % CI 1.4-3.9, p = 0.002) after PCI for STEMI.
CONCLUSIONS: Discordant elevation of cTnT in the presence of normal CK plasma levels on admission is associated with increased mortality in STEMI patients undergoing primary PCI. This may be due to preceding microembolization.

Entities:  

Keywords:  Cardiac biomarkers; Embolization; Mortality; ST-segment elevation myocardial infarction

Mesh:

Substances:

Year:  2015        PMID: 26563201     DOI: 10.1007/s00392-015-0938-9

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  31 in total

1.  Histopathology of aspirated thrombus and its association with ST-segment recovery in patients undergoing primary percutaneous coronary intervention with routine thrombus aspiration.

Authors:  Niels J W Verouden; Miranda C Kramer; XiaoFei Li; Martijn Meuwissen; Karel T Koch; José P S Henriques; Jan Baan; Marije M Vis; Jan J Piek; Allard C van der Wal; Jan G P Tijssen; Robbert J de Winter
Journal:  Catheter Cardiovasc Interv       Date:  2011-01-01       Impact factor: 2.692

2.  Results from a multicenter evaluation of the 4th generation Elecsys Troponin T assay.

Authors:  D Hermsen; F Apple; L Garcia-Beltràn; A Jaffe; B Karon; E Lewandrowski; A Mühlbacher; R Müller; J Ordóñez; F Pagani; M Panteghini; T Plecko; J Jarausch
Journal:  Clin Lab       Date:  2007       Impact factor: 1.138

3.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White; Kristian Thygesen; Joseph S Alpert; Harvey D White; Allan S Jaffe; Hugo A Katus; Fred S Apple; Bertil Lindahl; David A Morrow; Bernard R Chaitman; Peter M Clemmensen; Per Johanson; Hanoch Hod; Richard Underwood; Jeroen J Bax; Jeroen J Bonow; Fausto Pinto; Raymond J Gibbons; Keith A Fox; Dan Atar; L Kristin Newby; Marcello Galvani; Christian W Hamm; Barry F Uretsky; Ph Gabriel Steg; William Wijns; Jean-Pierre Bassand; Phillippe Menasche; Jan Ravkilde; E Magnus Ohman; Elliott M Antman; Lars C Wallentin; Paul W Armstrong; Maarten L Simoons; James L Januzzi; Markku S Nieminen; Mihai Gheorghiade; Gerasimos Filippatos; Russell V Luepker; Stephen P Fortmann; Wayne D Rosamond; Dan Levy; David Wood; Sidney C Smith; Dayi Hu; Jose-Luis Lopez-Sendon; Rose Marie Robertson; Douglas Weaver; Michal Tendera; Alfred A Bove; Alexander N Parkhomenko; Elena J Vasilieva; Shanti Mendis; Jeroen J Bax; Helmut Baumgartner; Claudio Ceconi; Veronica Dean; Christi Deaton; Robert Fagard; Christian Funck-Brentano; David Hasdai; Arno Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Theresa McDonagh; Cyril Moulin; Bogdan A Popescu; Zeljko Reiner; Udo Sechtem; Per Anton Sirnes; Michal Tendera; Adam Torbicki; Alec Vahanian; Stephan Windecker; Joao Morais; Carlos Aguiar; Wael Almahmeed; David O Arnar; Fabio Barili; Kenneth D Bloch; Ann F Bolger; Hans Erik Botker; Biykem Bozkurt; Raffaele Bugiardini; Christopher Cannon; James de Lemos; Franz R Eberli; Edgardo Escobar; Mark Hlatky; Stefan James; Karl B Kern; David J Moliterno; Christian Mueller; Aleksandar N Neskovic; Burkert Mathias Pieske; Steven P Schulman; Robert F Storey; Kathryn A Taubert; Pascal Vranckx; Daniel R Wagner
Journal:  J Am Coll Cardiol       Date:  2012-09-05       Impact factor: 24.094

4.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Authors:  C P Cannon; W S Weintraub; L A Demopoulos; R Vicari; M J Frey; N Lakkis; F J Neumann; D H Robertson; P T DeLucca; P M DiBattiste; C M Gibson; E Braunwald
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

5.  Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction.

Authors:  F J Neumann; A Kastrati; C Schmitt; R Blasini; M Hadamitzky; J Mehilli; M Gawaz; M Schleef; M Seyfarth; J Dirschinger; A Schömig
Journal:  J Am Coll Cardiol       Date:  2000-03-15       Impact factor: 24.094

6.  Admission troponin T level predicts clinical outcomes, TIMI flow, and myocardial tissue perfusion after primary percutaneous intervention for acute ST-segment elevation myocardial infarction.

Authors:  E Giannitsis; M Müller-Bardorff; S Lehrke; U Wiegand; R Tölg; B Weidtmann; F Hartmann; G Richardt; H A Katus
Journal:  Circulation       Date:  2001-08-07       Impact factor: 29.690

7.  Elevated troponin I level on admission is associated with adverse outcome of primary angioplasty in acute myocardial infarction.

Authors:  S Matetzky; T Sharir; M Domingo; M Noc; K Y Chyu; S Kaul; N Eigler; P K Shah; B Cercek
Journal:  Circulation       Date:  2000-10-03       Impact factor: 29.690

8.  Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction.

Authors:  H A Katus; A Remppis; T Scheffold; K W Diederich; W Kuebler
Journal:  Am J Cardiol       Date:  1991-06-15       Impact factor: 2.778

9.  Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction.

Authors:  Roberto R Giraldez; Marc S Sabatine; David A Morrow; Satishkumar Mohanavelu; Carolyn H McCabe; Elliott M Antman; Eugene Braunwald
Journal:  Am Heart J       Date:  2009-03       Impact factor: 4.749

10.  Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. Analysis of 28 months of follow-up in 196 patients.

Authors:  J Ravkilde; H Nissen; M Hørder; K Thygesen
Journal:  J Am Coll Cardiol       Date:  1995-03-01       Impact factor: 24.094

View more
  6 in total

1.  Circadian rhythm of blood cardiac troponin T concentration.

Authors:  Stephane Fournier; Lea Iten; Pedro Marques-Vidal; Olivier Boulat; Daniel Bardy; Ahmed Beggah; Rachel Calderara; Beata Morawiec; Nathalie Lauriers; Pierre Monney; Juan F Iglesias; Patrizio Pascale; Brahim Harbaoui; Eric Eeckhout; Olivier Muller
Journal:  Clin Res Cardiol       Date:  2017-08-30       Impact factor: 5.460

2.  Intra-procedural determination of viability by myocardial deformation imaging: a randomized prospective study in the cardiac catheter laboratory.

Authors:  Alexander Schuh; Vadim Karayusuf; Ertunc Altiok; Sandra Hamada; Jörg Schröder; Andras Keszei; Malte Kelm; Matias de la Fuente; Michael Frick; Klaus Radermacher; Nikolaus Marx; Michael Becker
Journal:  Clin Res Cardiol       Date:  2017-03-20       Impact factor: 5.460

3.  Association between admission anemia and long-term mortality in patients with acute myocardial infarction: results from the MONICA/KORA myocardial infarction registry.

Authors:  Miriam Giovanna Colombo; Inge Kirchberger; Ute Amann; Margit Heier; Christian Thilo; Bernhard Kuch; Annette Peters; Christa Meisinger
Journal:  BMC Cardiovasc Disord       Date:  2018-03-09       Impact factor: 2.298

4.  Both baseline Selvester QRS score and change in QRS score predict prognosis in patients with acute ST-segment elevation myocardial infarction after percutaneous coronary intervention.

Authors:  Qian Liu; Yong Zhang; Pengqiang Zhang; Junbo Zhang; Xiaojiao Cao; Shanshan He; Donghui Yang
Journal:  Coron Artery Dis       Date:  2020-08       Impact factor: 1.717

5.  Prognostic Implications of the Admission Cardiac Troponin I Levels and Door-to-Balloon Time on Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.

Authors:  Longguo Zhao; Minglong Xin; Xianji Piao; Shengming Zhang; Yanglong Li; Xian Wu Cheng
Journal:  Ther Clin Risk Manag       Date:  2022-01-07       Impact factor: 2.423

6.  Relationship Between Troponin on Presentation and In-Hospital Mortality in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Brett L Wanamaker; Milan M Seth; Devraj Sukul; Simon R Dixon; Deepak L Bhatt; Ryan D Madder; John S Rumsfeld; Hitinder S Gurm
Journal:  J Am Heart Assoc       Date:  2019-09-24       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.